Establishing Quality Control Ranges for Antimicrobial Susceptibility Testing of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus: A Cornerstone to Develop Reference Strains for Korean Clinical Microbiology Laboratories
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Quality control (QC) processes are being performed in the majority of clinical microbiology laboratories to ensure the performance of microbial identification and antimicrobial susceptibility testing by using ATCC strains. To obtain these ATCC strains, some inconveniences are encountered concerning the purchase cost of the strains and the shipping time required. This study was focused on constructing a database of reference strains for QC processes using domestic bacterial strains, concentrating primarily on antimicrobial susceptibility testing. Three strains (Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus) that showed legible results in preliminary testing were selected. The minimal inhibitory concentrations (MICs) and zone diameters (ZDs) of eight antimicrobials for each strain were determined according to the CLSI M23. All resulting MIC and ZD ranges included at least 95% of the data. The ZD QC ranges obtained by using the CLSI method were less than 12 mm, and the MIC QC ranges extended no more than five dilutions. This study is a preliminary attempt to construct a bank of Korean QC strains. With further studies, a positive outcome toward cost and time reduction can be anticipated.
Abstract
Quality control (QC) processes are being performed in the majority of clinical microbiology laboratories to ensure the performance of microbial identification and antimicrobial susceptibility testing by using ATCC strains. To obtain these ATCC strains, some inconveniences are encountered concerning the purchase cost of the strains and the shipping time required. This study was focused on constructing a database of reference strains for QC processes using domestic bacterial strains, concentrating primarily on antimicrobial susceptibility testing. Three strains (Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus) that showed legible results in preliminary testing were selected. The minimal inhibitory concentrations (MICs) and zone diameters (ZDs) of eight antimicrobials for each strain were determined according to the CLSI M23. All resulting MIC and ZD ranges included at least 95% of the data. The ZD QC ranges obtained by using the CLSI method were less than 12 mm, and the MIC QC ranges extended no more than five dilutions. This study is a preliminary attempt to construct a bank of Korean QC strains. With further studies, a positive outcome toward cost and time reduction can be anticipated.
참고문헌 (9)
- Turnidge J, "Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing", Antimicrob Agents Chemother, 51, pp.2483~2488 (2007)
- Clinical and Laboratory Standards Institute, "Development of in vitro susceptibility testing criteria and quality control parameters; approved guideline-third ed. M23-A3", Clinical and Laboratory Standards Institute, ~ (2008)
- Gavan TL, "Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study", J Clin Microbiol, 14, pp.67~72 (1981)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Twenty-second informational supplement, M100-S22", Clinical Laboratory Standards Institute, ~ (2012)
- Clinical and Laboratory Standards Institute, "Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-eighth ed. M07-A8", Clinical and Laboratory Standards Institute, ~ (2009)
- Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial disk susceptibility tests; approved standard-tenth ed. M02-A10", Clinical and Laboratory Standards Institute, ~ (2009)
- Kuper KM, "Antimicrobial susceptibility testing: a primer for clinicians", Pharmacotherapy, 29, pp.1326~1343 (2009)
- 신소연, "Evaluation of the Vitek 2 Korean Antimicrobial Susceptibility Testing Cards AST N056 and AST N055", Annals of Clinical Microbiology, 11(1), pp.23~28 (2008), 대한임상미생물학회
- Sarah W Njoroge, "Risk Management in the Clinical Laboratory", Annals of Laboratory Medicine, 34(4), pp.274~278 (2014), 대한진단검사의학회